Literature DB >> 26298099

Risk-stratified postnatal care of newborns with congenital heart disease determined by fetal echocardiography.

Mary T Donofrio1, Kami Skurow-Todd2, John T Berger3, Robert McCarter4, Amanda Fulgium2, Anita Krishnan2, Craig A Sable2.   

Abstract

BACKGROUND: Advances in fetal echocardiography have improved recognition of congenital heart disease (CHD). Imaging protocols have been developed that predict delivery room (DR) risk and anticipated postnatal level of care (LOC). The aim of this study was to determine the utility of fetal echocardiography in the perinatal management of CHD.
METHODS: A retrospective analysis of fetal and postnatal records was conducted. The anticipated LOC was assigned by fetal echocardiography (LOC 1, nursery consult/outpatient follow-up; LOC 2, stable in DR with transfer to cardiac hospital; LOC 3 or 4, DR instability/urgent intervention needed). Prenatal diagnoses and LOC assignment were compared with postnatal diagnoses, treatment, and short-term outcomes.
RESULTS: From 2004 to 2012, 8,101 fetuses were evaluated; 7,405 were normal. Of 696 with CHD, 101 terminated, 40 died in utero, and 37 received palliative care. LOC was assigned in the remaining 518. Of 219 LOC 1, 195 (89%) had postnatal follow-up. Only two required transfer for intervention (LOC 1 sensitivity, 0.9; LOC 1 positive predictive value, 0.99). Of 260 assigned LOC 2, 229 (88%) had follow-up. Of these, 200 (87%) were transferred for surgery or intervention. The median time to admission was 195 min. Twenty-two patients (10%) assigned LOC 2 did not require intervention; however, seven (all with D-transposition of the great arteries) required catheter intervention before surgery. Hospital survival was 86% (LOC 2 sensitivity, 0.97; LOC 2 positive predictive value, 0.87). All LOC 3 and 4 patients had follow-up. Thirty-four (87%) needed urgent intervention, with 100% DR and 87% hospital survival (LOC 3 and 4 sensitivity, 0.83; LOC 3 and 4 positive predictive value, 0.87).
CONCLUSIONS: Fetal echocardiography enables accurate postnatal risk stratification in CHD, with the exception of D-transposition of the great arteries. LOC 1 assignment facilitated outpatient follow-up; LOC 2 assignment facilitated transfer for intervention. LOC 3 and 4 patients underwent stabilizing intervention or surgery with good short-term outcomes. Given the inability to predict need for intervention in D-transposition of the great arteries, all such patients should be assigned as LOC 3 or 4. Fetal echocardiography with LOC assignment should be used in the planning of postnatal care in CHD.
Copyright © 2015 American Society of Echocardiography. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Congenital heart disease; Fetal cardiology; Fetal echocardiography

Mesh:

Year:  2015        PMID: 26298099     DOI: 10.1016/j.echo.2015.07.005

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  11 in total

Review 1.  Fetal cardiology: changing the definition of critical heart disease in the newborn.

Authors:  M Słodki; M Respondek-Liberska; J D Pruetz; M T Donofrio
Journal:  J Perinatol       Date:  2016-03-10       Impact factor: 2.521

2.  Care Levels for Fetal Therapy Centers.

Authors:  Ahmet A Baschat; Sean B Blackwell; Debnath Chatterjee; James J Cummings; Stephen P Emery; Shinjiro Hirose; Lisa M Hollier; Anthony Johnson; Sarah J Kilpatrick; Francois I Luks; M Kathryn Menard; Lawrence B McCullough; Julie S Moldenhauer; Anita J Moon-Grady; George B Mychaliska; Michael Narvey; Mary E Norton; Mark D Rollins; Eric D Skarsgard; KuoJen Tsao; Barbara B Warner; Abigail Wilpers; Greg Ryan
Journal:  Obstet Gynecol       Date:  2022-05-02       Impact factor: 7.623

3.  Dextro-transposition of great vessels: difficult to detect prenatally, one of the most dangerous and one of the best prognosed.

Authors:  Maciej Słodki
Journal:  Transl Pediatr       Date:  2022-06

4.  Distance from home to birth hospital, transfer, and mortality in neonates with hypoplastic left heart syndrome in California.

Authors:  Neha J Purkey; Chen Ma; Henry C Lee; Susan R Hintz; Gary M Shaw; Doff B McElhinney; Suzan L Carmichael
Journal:  Birth Defects Res       Date:  2022-04-29       Impact factor: 2.661

5.  Improving maternal-infant bonding after prenatal diagnosis of CHD.

Authors:  Piers C A Barker; Gregory H Tatum; Michael J Campbell; Michael G W Camitta; Angelo S Milazzo; Christoph P Hornik; Amanda French; Stephen G Miller
Journal:  Cardiol Young       Date:  2018-08-06       Impact factor: 1.093

Review 6.  Fetal cardiac function by three-dimensional ultrasound using 4D-STIC and VOCAL - an update.

Authors:  Nathalie Jeanne Bravo-Valenzuela; Alberto Borges Peixoto; Milene Carvalho Carrilho; Ana Letícia Siqueira Pontes; Caroline Cevante Chagas; Christiane Simioni; Edward Araujo Júnior
Journal:  J Ultrason       Date:  2019-12-31

7.  Prenatal cardiac care: Goals, priorities & gaps in knowledge in fetal cardiovascular disease: Perspectives of the Fetal Heart Society.

Authors:  Nelangi M Pinto; Shaine A Morris; Anita J Moon-Grady; Mary T Donofrio
Journal:  Prog Pediatr Cardiol       Date:  2020-10-17

8.  Delivery Outcome of Fetuses with Congenital Heart Disease-Is It Influenced by Prenatal Diagnosis?

Authors:  Alina Weissmann-Brenner; Noam Domniz; Raanan Meyer; Tal Weissbach; Tal Elkan; Yishai Salem; Yossi Bart; Eran Kassif; Boaz Weisz
Journal:  J Clin Med       Date:  2022-07-14       Impact factor: 4.964

9.  Hypothermia for cardiogenic encephalopathy in neonates with dextro-transposition of the great arteries.

Authors:  Vinzenz Boos; Christoph Bührer; Joachim Photiadis; Felix Berger
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-01-01

Review 10.  Redefining the Relationship: Palliative Care in Critical Perinatal and Neonatal Cardiac Patients.

Authors:  Natasha S Afonso; Margaret R Ninemire; Sharada H Gowda; Jaime L Jump; Regina L Lantin-Hermoso; Karen E Johnson; Kriti Puri; Kyle D Hope; Erin Kritz; Barbara-Jo Achuff; Lindsey Gurganious; Priya N Bhat
Journal:  Children (Basel)       Date:  2021-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.